HUMANA INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary: Humana Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2017 to Q3 2024.
Humana Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending September 30, 2024 was $635M, a 41.5% decline year-over-year.
Humana Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending September 30, 2024 was $1.91B, a 50.5% decline year-over-year.
Humana Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $3.32B, a 6.85% decline from 2022.
Humana Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $3.56B, a 4.24% increase from 2021.
Humana Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was $3.42B, a 26.9% decline from 2020.

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$1.91B	$635M	-$451M	-41.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-30
Q2 2024	$2.36B	$901M	-$351M	-28%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-31
Q1 2024	$2.71B	$990M	-$607M	-38%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-24
Q4 2023	$3.32B	-$615M	-$539M	-709%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-15
Q3 2023	$3.86B	$1.09B	-$214M	-16.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-30
Q2 2023	$4.07B	$1.25B	+$128M	+11.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-31
Q1 2023	$3.95B	$1.6B	+$381M	+31.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-24
Q4 2022	$3.56B	-$76M	-$12M	-18.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-15
Q3 2022	$3.58B	$1.3B	-$351M	-21.3%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-01
Q2 2022	$3.93B	$1.12B	+$353M	+45.8%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-02
Q1 2022	$3.57B	$1.22B	+$155M	+14.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-26
Q4 2021	$3.42B	-$64M	+$388M	+85.8%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-15
Q3 2021	$3.03B	$1.65B	-$139M	-7.77%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	$3.17B	$771M	-$1.84B	-70.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-07-27
Q1 2021	$5.01B	$1.06B	+$336M	+46.3%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-27
Q4 2020	$4.67B	-$452M	-$1.04B	-176%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-16
Q3 2020	$5.72B	$1.79B	+$901M	+101%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$4.82B	$2.61B	+$1.37B	+110%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-28
Q1 2020	$3.45B	$725M	-$24M	-3.2%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-28
Q4 2019	$3.47B	$591M	+$153M	+34.9%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-17
Q3 2019	$3.32B	$889M	-$21M	-2.31%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-03
Q2 2019	$3.34B	$1.24B	+$1.22B	+6432%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	$2.12B	$749M	+$42M	+5.94%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-29
Q4 2018	$2.07B	$438M			Oct 1, 2018	Dec 31, 2018	10-K	2021-02-18
Q3 2018		$910M	+$111M	+13.9%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-06
Q2 2018		$19M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-31
Q1 2018		$707M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-01
Q3 2017		$799M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.